Common use of Research Data Reporting Clause in Contracts

Research Data Reporting. Upon completion of any such studies described in Section 3.3 of this Agreement, Licensee shall furnish free of charge to Pfizer and its Affiliates in the English language all data and information, especially any adverse drug experiences, derived from any such studies (including Clinical Trials) carried out by Licensee relating to the Licensed Product, in such detail and DocuSign Envelope ID: D912197B-D81E-47C3-A57B-57CF17C9819B at such times as Pfizer may reasonably request for regulatory purposes, use in connection with the exercise of the licenses granted to Pfizer under Sections 6.1 or 6.2, other non-commercial and internal use and disclosure to any Third Party in compliance with the contractual obligations of Pfizer and its Affiliates. Any such Affiliates which are recipients of such information pursuant to the foregoing shall be under the same obligation of confidentiality as set forth in this Section. If Pfizer and its Affiliates want to use the data and information for any other purpose, Licensee and Pfizer shall negotiate in good faith.

Research Data Reporting. Upon completion of any such studies described in Section 3.3 of this Agreement, Licensee shall furnish free of charge to Pfizer and its Affiliates in the English language all data and information, especially any adverse drug experiences, derived from any such studies (including Clinical Trials) carried out by Licensee relating to the Licensed Product, in such detail and DocuSign Envelope ID: D912197B91216EB2-D81E-47C3F486-A57B-57CF17C9819B 414B-B694-F90CEB5F065E at such times as Pfizer may reasonably request for regulatory purposes, use in connection with the exercise of the licenses granted to Pfizer under Sections 6.1 or 6.2, other non-commercial and internal use and disclosure to any Third Party in compliance with the contractual obligations of Pfizer and its Affiliates. Any such Affiliates which are recipients of such information pursuant to the foregoing shall be under the same obligation of confidentiality as set forth in this Section. If Pfizer and its Affiliates want to use the data and information for any other purpose, Licensee and Pfizer shall negotiate in good faith.

Research Data Reporting. Upon completion of any such studies described in Section 3.3 of this Agreement, Licensee shall furnish free of charge to Pfizer and its Affiliates in the English language all data and information, especially any adverse drug experiences, derived from any such studies (including Clinical Trials) carried out by Licensee relating to the Licensed Product, in such detail and DocuSign Envelope ID: D912197BE389DDA3-D81E-47C33EA0-A57B-57CF17C9819B 4C1B-801D-93CD35BC54C2 at such times as Pfizer may reasonably request for regulatory purposes, use in connection with the exercise of the licenses granted to Pfizer under Sections 6.1 or 6.2, other non-commercial and internal use and disclosure to any Third Party in compliance with the contractual obligations of Pfizer and its Affiliates. Any such Affiliates which are recipients of such information pursuant to the foregoing shall be under the same obligation of confidentiality as set forth in this Section. If Pfizer and its Affiliates want to use the data and information for any other purpose, Licensee and Pfizer shall negotiate in good faith.

Research Data Reporting. Upon completion of any such studies described in Section 3.3 of this Agreement, Licensee shall furnish free of charge to Pfizer and its Affiliates in the English language all data and information, especially any adverse drug experiences, derived from any such studies (including Clinical Trials) carried out by Licensee relating to the Licensed Product, in such detail and DocuSign Envelope ID: D912197B20ED8EAA-71E5-D81E-47C34C18-A57B-57CF17C9819B B49D-62DBEC763D25 at such times as Pfizer may reasonably request for regulatory purposes, use in connection with the exercise of the licenses granted to Pfizer under Sections 6.1 or 6.2, other non-commercial and internal use and disclosure to any Third Party in compliance with the contractual obligations of Pfizer and its Affiliates. Any such Affiliates which are recipients of such information pursuant to the foregoing shall be under the same obligation of confidentiality as set forth in this Section. If Pfizer and its Affiliates want to use the data and information for any other purpose, Licensee and Pfizer shall negotiate in good faith.

Research Data Reporting. Upon completion of any such studies described in Section 3.3 of this Agreement, Licensee shall furnish free of charge to Pfizer and its Affiliates in the English language all data and information, especially any adverse drug experiences, derived from any such studies (including Clinical Trials) carried out by Licensee relating to the Licensed Product, in such detail and DocuSign Envelope ID: D912197B174398E9-D81E-47C37BC6-A57B-57CF17C9819B 4D69-97DC-01A43A37BFC6 at such times as Pfizer may reasonably request for regulatory purposes, use in connection with the exercise of the licenses granted to Pfizer under Sections 6.1 or 6.2, other non-commercial and internal use and disclosure to any Third Party in compliance with the contractual obligations of Pfizer and its Affiliates. Any such Affiliates which are recipients of such information pursuant to the foregoing shall be under the same obligation of confidentiality as set forth in this Section. If Pfizer and its Affiliates want to use the data and information for any other purpose, Licensee and Pfizer shall negotiate in good faith.

Research Data Reporting. Upon completion of any such studies described in Section 3.3 of this Agreement, Licensee shall furnish free of charge to Pfizer and its Affiliates in the English language all data and information, especially any adverse drug experiences, derived from any such studies (including Clinical Trials) carried out by Licensee relating to the Licensed Product, in such detail and DocuSign Envelope ID: D912197BF0C62F1B-D81E-47C3BD77-A57B-57CF17C9819B 4D06-9219-67924AA8E188 at such times as Pfizer may reasonably request for regulatory purposes, use in connection with the exercise of the licenses granted to Pfizer under Sections 6.1 or 6.2, other non-commercial and internal use and disclosure to any Third Party in compliance with the contractual obligations of Pfizer and its Affiliates. Any such Affiliates which are recipients of such information pursuant to the foregoing shall be under the same obligation of confidentiality as set forth in this Section. If Pfizer and its Affiliates want to use the data and information for any other purpose, Licensee and Pfizer shall negotiate in good faith.

Research Data Reporting. Upon completion of any such studies described in Section 3.3 of this Agreement, Licensee shall furnish free of charge to Pfizer and its Affiliates in the English language all data and information, especially any adverse drug experiences, derived from any such studies (including Clinical Trials) carried out by Licensee relating to the Licensed Product, in such detail and DocuSign Envelope ID: D912197BE68F63E3-D81E-47C3D274-A57B-57CF17C9819B 4CA3-9C96-ECE5CBD30F63 at such times as Pfizer may reasonably request for regulatory purposes, use in connection with the exercise of the licenses granted to Pfizer under Sections 6.1 or 6.2, other non-commercial and internal use and disclosure to any Third Party in compliance with the contractual obligations of Pfizer and its Affiliates. Any such Affiliates which are recipients of such information pursuant to the foregoing shall be under the same obligation of confidentiality as set forth in this Section. If Pfizer and its Affiliates want to use the data and information for any other purpose, Licensee and Pfizer shall negotiate in good faith.

Research Data Reporting. Upon completion of any such studies described in Section 3.3 of this Agreement, Licensee shall furnish free of charge to Pfizer and its Affiliates in the English language all data and information, especially any adverse drug experiences, derived from any such studies (including Clinical Trials) carried out by Licensee relating to the Licensed Product, in such detail and DocuSign Envelope ID: D912197B76B8C7A6-D81E-47C366D1-A57B-57CF17C9819B 43C9-84E7-0D151DB61944 at such times as Pfizer may reasonably request for regulatory purposes, use in connection with the exercise of the licenses granted to Pfizer under Sections 6.1 or 6.2, other non-commercial and internal use and disclosure to any Third Party in compliance with the contractual obligations of Pfizer and its Affiliates. Any such Affiliates which are recipients of such information pursuant to the foregoing shall be under the same obligation of confidentiality as set forth in this Section. If Pfizer and its Affiliates want to use the data and information for any other purpose, Licensee and Pfizer shall negotiate in good faith.